BlackRock Inc. - NEOLEUKIN THERAPEUTICS INC ownership

NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 53 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$401,677
+1.7%
483,948
-14.3%
0.00%
Q1 2023$395,133
+26.4%
564,475
-8.1%
0.00%
Q4 2022$312,497
-45.1%
613,942
-31.0%
0.00%
Q3 2022$569,000
-39.3%
889,298
-2.4%
0.00%
Q2 2022$938,000
-80.5%
910,832
-64.4%
0.00%
Q1 2022$4,810,000
-61.7%
2,558,479
-1.8%
0.00%
Q4 2021$12,555,000
-34.9%
2,604,645
-2.4%
0.00%
-100.0%
Q3 2021$19,299,000
-20.8%
2,669,276
+1.2%
0.00%0.0%
Q2 2021$24,358,000
-27.0%
2,638,758
-2.6%
0.00%0.0%
Q1 2021$33,358,000
-11.9%
2,709,825
+0.9%
0.00%0.0%
Q4 2020$37,857,000
+40.8%
2,684,910
+19.8%
0.00%0.0%
Q3 2020$26,885,000
-26.0%
2,240,550
+2.4%
0.00%0.0%
Q2 2020$36,310,000
+425.6%
2,187,273
+260.3%
0.00%
Q1 2020$6,908,000
-7.5%
607,032
+0.1%
0.00%
Q4 2019$7,472,000
+746.2%
606,462
+95.7%
0.00%
Q3 2019$883,000309,8400.00%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,386,300$19,547,0002.55%
EcoR1 Capital, LLC 3,122,704$44,030,0002.37%
Redmile Group, LLC 4,131,869$58,259,0000.70%
Boxer Capital, LLC 1,501,058$21,165,0000.68%
HighVista Strategies LLC 69,727$983,0000.63%
Baker Brothers Advisors 3,821,740$53,887,0000.20%
Highland Private Wealth Management 93,998$1,326,0000.12%
Sio Capital Management, LLC 38,312$540,0000.11%
Point72 Asset Management, L.P. 1,195,725$16,860,0000.08%
Granahan Investment Management 246,299$3,473,0000.08%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders